Scotia Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,848
Closed -$203K 943
2026
Q1
$203K Sell
2,848
-20,978
-88% -$1.65M ﹤0.01% 856
2025
Q4
$1.95M Sell
23,826
-214
-0.9% -$16.7K 0.01% 456
2025
Q3
$1.81M Buy
24,040
+929
+4% +$69.3K 0.01% 464
2025
Q2
$1.71M Buy
23,111
+3,900
+20% +$271K 0.01% 443
2025
Q1
$1.55M Buy
19,211
+2,430
+14% +$209K 0.01% 440
2024
Q4
$1.31M Buy
16,781
+828
+5% +$70.4K 0.01% 471
2024
Q3
$1.5M Buy
15,953
+2,618
+20% +$220K 0.01% 435
2024
Q2
$1.04M Buy
13,335
+6,822
+105% +$556K 0.01% 487
2024
Q1
$592K Buy
6,513
+3,397
+109% +$283K ﹤0.01% 576
2023
Q4
$241K Sell
3,116
-130
-4% -$9.1K ﹤0.01% 706
2023
Q3
$221K Sell
3,246
-88
-3% -$6.4K ﹤0.01% 697
2023
Q2
$271K Sell
3,334
-1,711
-34% -$137K ﹤0.01% 670
2023
Q1
$414K Buy
+5,045
New +$360K ﹤0.01% 582

Other funds holding GEHC

Scotia Capital's GEHC Position: Q2 2026 in Review

Scotia Capital sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 2,848 shares — an estimated $203K sold.

Scotia Capital first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $1.95M in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Scotia Capital reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Scotia Capital sold 2,848 GE HealthCare shares in Q2 2026, an estimated $203K.
  • Scotia Capital first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Scotia Capital's GE HealthCare position peaked at $1.95M in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.